Research

With the HERA Incubator, the EC launched an initiative to keep coronavirus variants at bay and prepare for a permanent authority in the fight against pandemics.

The EU’s Beating Cancer Plan covers the entire disease pathway from prevention to quality of life and focuses strongly on R&I as a means to combat cancer.

The EC consults on healthy ageing and measures mitigating demographic change with a Green Paper taking a life cycle approach and considering all generations.

A new report by the European University Association provides guidance for reimagining academic career assessment with a set of case studies and recommendations.

COVID-19 had a deep impact on research infrastructures, but it provides a chance to improve remote operations with benefits for users and the environment.

The fifth monitoring report on SSH integration in H2020 shows that despite a quantitative increase more efforts with respect to quality are needed.

The European Commission’s policy outline for a more inclusive, more ambitious New European Research Area finds approval with the Council to be taken forward.

The EC’s ‘Open Research Europe’ Open Access publishing platform will facilitate the sharing of research results, but scientists see some flaws in the system.

The new Pharmaceutical Strategy of the European Commission features R&I, and related programmes among its most prominent areas for support.

Data will play a crucial role for the success of Horizon Europe missions. Examples from the soil and cancer mission show first advances and potential challenges.